Sandra Garrett ConnectPreneur Presentation

Good morning. Before I start, I have a question for the audience. By a show of hands, how many of you and members of your family who take prescription medication have concerns about the side effects? The second part of that question: how many of you, by a show of hands, watch a commercial on television every three and a half seconds on every TV channel that advertises a medical product and gives you the side effect profile, and you say to yourself, 'What will happen to me?' Show hands. Well, that's our mission. All of you with hands raised. We provide you and members of your family with real-world data related to the risks and benefits of the drugs you take. We have built a digital platform that's an early warning system to identify potential negative side effects of both medications and devices. Each year, approximately 77 new drugs are approved by the FDA, and they are approved with a limited amount of data about the safety, side effects, and overall efficacy. We don't know anything about the real-world effects until people in the community worldwide take that medication for a prolonged period of time. In order to have meaningful data, the information must come from you directly, you the patient. The question in the medical community and faced by our company is: who's listening to your voice, or who's listening to the voice of the patient? We are. We have built the National Medication Safety Outcomes and Adherence Program to bring together patients, pharmacists, and physicians to look at early warning signs of drugs for newly approved drugs and devices on the market. To date, we have recruited 10,000 patients from pharmacies and doctor's offices across the country. We enroll them in our HIPAA-compliant study, and what we do works for the patient, their advocates, and their family. Patients complete digital surveys every month at home, at the pharmacy when they go to pick up their refills, or with the help of our call center. We then integrate the data from their medical records, their pharmacy data, and their claims data to provide one of the most comprehensive and robust profiles of drug safety and efficacy. When the patient returns to the pharmacy, the pharmacist reviews the changes from the previous month's survey, and if there are any highlighted areas of concern, the pharmacist and patient immediately reach out to call the physician. Patients participate in our program because they want to know how other patients just like themselves with the same profile are reacting to the drug. As an example, think about the patient who says, 'I'm a Caucasian female. I'm 56 years old. I have atrial fibrillation. I have a history of diabetes and I've had a recent heart attack. My physician just put me on Xarelto. But every time I watch that television ad for Xarelto and the ad says that I can bleed in my gut or I can bleed in my head, I want to know how many patients like me have had a stroke by taking that drug.' Our stakeholders are pharmaceutical companies, health insurers, physicians, and most importantly, you, the patient. For health insurers, we compare and contrast effectiveness of drugs and cost effectiveness of treatment. Also for the payers who want to know whether physicians are following the appropriate treatment. All the stakeholders want to track if patients are taking the drugs as prescribed. We develop models that can predict whether the drug works long-term or not, whether patients develop complications from treatment, and even if they will live long-term. Our business model: we make money from two sources. Number one, we customize data collection programs for our customers. In fact, we currently have a $5.4 million contract waiting for startup and several others in negotiation with pharmaceutical companies and payers. And number two, when our database becomes large enough, we'll sell subscriptions to access the information. So if you have atrial fibrillation, high cholesterol, or you take Remicade for your rheumatoid arthritis, in the upcoming months, you may be able to enroll in one of our programs at your local Rite Aid, or your ShopRite Food Warehouse, or your Safeway pharmacy. The executive team is made up of four founders. We have known each other for years. We've all worked together in other healthcare-related companies, and all of us have had successful exits from the companies that we have developed. We raised $2.5 million to date, primarily from 35 physicians in this community who are specialists across multiple therapeutic areas. They serve as our consultants and bring significant validity to our products. We want to raise $5 million primarily to scale our technologies and to build a national program using disruptive technologies that genuinely serve the public health. We have a business model that projects a healthy return on investment. We have a management team who've been in the business for 125 years collectively. It's not me alone. With the FDA as a partner, that helps us to implement risk mitigation strategies by recommending our platform to biopharmaceutical companies and payers. The FDA as our partner turned out to be both our carrot and our stick, and we're working with companies such as IBM and Watson in anticipation of our exit. In terms of milestones and fundraising, the use of our funds is to scale the enterprise, to grow our stack call center, to build disruptive analytics with IBM using artificial intelligence from Watson. We are really the first mover for advantage, especially through our partnership with the agency and our physician consultants and our long history of work with pharmaceutical companies. And given the view of the current presidential administration, Medi Merchant really does have the wind in our sails. Our technologies will help to accelerate time to market, and our early warning system will reduce costs by keeping patients out of the emergency room and hospital. We thank you for the opportunity to address you today, and we hope that you will review our disruptive product and service not only as a viable investment but as a system that empowers patients to be more vigilant about their health and disease. Thank you.